Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
The DOI matches its Crossref record; 24 of the 26 references it cites were found in a registry or an index.
Abstract
Background CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy) is commonly overlooked or misdiagnosed owing to its recent identification and its variable mode of presentation. The defective gene in CADASIL is Notch3, which encodes a large transmembrane receptor. To set up a diagnostic test and to delineate the Notch3 domains involved in CADASIL., we undertook mutations analysis in this gene in a group of CADASIL patients.Methods 50 unrelated patients with CADASIL and 100 healthy controls were screened for mutations along the entire Notch3 sequence, by means of single-strand conformation polymorphism, heteroduplex, and sequence analysis.Findings Strongly stereotyped mis-sense mutations, located within the epidermal-growth-factor-like (EGF-like) repeats, in the extracellular domain of Notch3, were detected in 45 patients. Clustering of mutations within the two exons encoding the first five EGF-like repeats was observed (32 patients). All these mutations lead to loss or gain of a cysteine residue and therefore to an unpaired number of cysteine residues within a given EGF domain. None of these mutations was found in the 100 controls.Interpretation Because of the strong clustering and highly stereotyped nature of the pathogenetic mutations detected in CADASIL patients, and easy and reliable diagnostic test for CADASIL is feasible. The findings suggest that aberrant dimerisation of Notch3, due to abnormal disulphide bridging with another Notch3 molecule or with another protein, may be involved in the pathogenesis of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.165”
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Self-citationArtavanis-Tsakonas, S., Matsuno, K., & Fortini, M. E. (1995) · Science · doi:10.1126/science.7716513 · Cited by 1,303
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., & Artavanis-Tsakonas, S. (1991) · Cell · doi:10.1016/0092-8674(91)90064-6 · Cited by 772
Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G. M., Chabriat, H., Mas, J.-L., Cabanis, E.-A., Baudrimont, M., Maciazek, J., et al. (1993) · Nature Genetics · doi:10.1038/ng0393-256 · Cited by 682
Self-citationClinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669
Self-citationRebay, I., Fehon, R. G., & Artavanis-Tsakonas, S. (1993) · Cell · doi:10.1016/0092-8674(93)90423-n · Cited by 409
Epidermal growth factor-like modules
Campbell, I. D., & Bork, P. (1993) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(05)80111-3 · Cited by 351
Ruchoux, M. M., Guerouaou, D., Vandenhaute, B., Pruvo, J.-P., Vermersch, P., & Leys, D. (1995) · Acta Neuropathologica · doi:10.1007/bf00571504 · Cited by 329
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study.
Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., & Bousser, M. G. (1993) · Stroke · doi:10.1161/01.str.24.1.122 · Cited by 321
Self-citation
Research works printed but not linked: 1
- Davous, 1991, Démence sous corticale familiale avec leucoencéphalopathie artériopathique: observation clinicopathologique., Rev Neurol (Paris), 5, 376
Cited by
Items 501–600 of 735
Silberstein, S. D., & Young, W. B. (2007) · Elsevier eBooks · doi:10.1016/b978-141603618-0.10053-0 · Cited by 5
Adachi, Y., & Nakashima, K. (2000) · Internal Medicine · doi:10.2169/internalmedicine.39.681 · Cited by 5
A Japanese Case of CADASIL with a Rare Mutation in Exon 24 of the NOTCH3 Gene
Ebihara, Y., Mochizuki, H., Ishii, N., Mizuta, I., Shiomi, K., Mizuno, T., & Nakazato, M. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0723-17 · Cited by 5
“The mutations are most frequent in exons 3-6 (3, 4), while the mutation in exon 24, which encodes the 3’ end of the EGF-like repeat, was previously identified in only two Italian families (5, 6).”
BackgroundClassification, pathology, and basic aspects
Pantoni, L., & Gorelick, P. B. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.002 · Cited by 5
Cartee, N. M. P., Lee, S. J., Wu, E., Sukpraphrute, R., Sukpraphrute, C., Greenbaum, J., & Wang, M. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108224 · Cited by 4
“The resulting mutant gene products contain an odd number of cysteine due to either loss or gain of a cysteine residue (3, 4).”
Hu, F., Xie, W., Fan, M., Wang, Y., Xu, S., Qiu, W., Yang, T., Lv, H., Huang, H., Wu, Y., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70100 · Cited by 4
“CADASIL mutations result in the loss or gain of a cysteine residue, causing an odd number of cysteine residues within an EGF domain [33].”
Cerfontaine, M. N., Gravesteijn, G., Hack, R. J., Dijkstra, K. L., Rodríguez‐Girondo, M., Gesierich, B. G., Witjes‐Ané, M. W., van Doorn, R., Duering, M., Rutten, J. W., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27240 · Cited by 4
Noura, M., Yasuda, T., Kiyoi, H., & Hayakawa, F. (2025) · The FASEB Journal · doi:10.1096/fj.202402997r · Cited by 4
Liu, X., Gonzalez-Toledo, M. E., Fagan, A., Duan, W., Liu, Y., Zhang, S., Li, B., Piao, C.-S., Nelson, L., & Zhao, L. (2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.434 · Cited by 4
“The cause of CADASIL disease is dominant mutations in the Notch3 gene encoding the Notch3 receptor [2, 3] .”
Novel mutation of the NOTCH3 gene in Arabic family with CADASIL
Bohlega, S. (2011) · Neurology International · doi:10.4081/ni.2011.e6 · Cited by 4
Zhang, C., Li, S., Li, W., Niu, S., Wang, X., & Zhang, Z. (2021) · European Neurology · doi:10.1159/000508950 · Cited by 4
Annals of Clinical Cytology and Pathology
Bowirrat, A. (2014) · Cited by 4
Notch3 protein expression in skin fibroblasts from CADASIL patients
Qualtieri, A., Ungaro, C., Bagalà, A., Bianchi, S., Pantoni, L., Moccia, M., & Mazzei, R. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.04.027 · Cited by 4
Neuropsychiatric Symptoms of CADASIL
Chabriat, H., & Reyes, S. (2013) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-1-4471-2428-3_10 · Cited by 4
Self-citationTrans-Reduction of Cerebral Small Vessel Disease Proteins by Notch-Derived EGF-like Sequences
Cartee, N. M. P., Lee, S. J., Young, K. Z., Zhang, X., & Wang, M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073671 · Cited by 4
“In CADASIL, mutations affecting the number of cysteines [17,18] result in a syndrome marked by cerebrovascular pathology leading to premature stroke and vascular dementia [19,20].”
BackgroundExamination of notch3 mutations in Japanese patients with leukoaraiosis without hypertension
Adachi, Y., Hayashi, M., & Nakashima, K. (2006) · Nosotchu · doi:10.3995/jstroke.28.585 · Cited by 4
First report of an Iraqi Kurdish CADASIL patient
Mignarri, A., Martini, G., Malandrini, A., Bellini, M., Bianchi, S., Tassi, R., Federico, A., & Dotti, M. T. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0399-x · Cited by 4
“Mutational analysis of NOTCH3 gene uncovered the c.3691C[T (p.Arg1231Cys) mutation in exon 22, already reported in patients with typical CADASIL features [ 5 ].”
Backgroundde Lange, R. P. J., Burr, K., Clark, J. S., Negrín, C. D., Brosnan, M. J., Clair, D. M. S., Dominiczak, A. F., & Shaw, D. J. (2001) · Neurogenetics · doi:10.1007/s100480000099 · Cited by 4
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in Arabs.
Bohlega, S., & Abu-Amero, K. K. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4384 · Cited by 4
Tsuji, S. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50006-2 · Cited by 4
Rutten, J. W., van Duinen, S. G., & Oberstein, S. A. J. L. (2015) · Stroke · doi:10.1161/strokeaha.115.009467 · Cited by 4
Hung, K., Chen, C.-H., Wu, W.-C., Su, J.-J., Chen, Y.-F., & Tang, S.-C. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105856 · Cited by 3
“The diagnosis of CADASIL was confirmed by genetic testing, specifically by detecting the NOTCH3 mutations (Joutel et al., 1997, Liao et al., 2015).”
Zhao, X., Yu, C., Adamson, A. D., Zhao, A., Zhou, H., Sharma, P., & Wang, T. (2026) · Science Advances · doi:10.1126/sciadv.aeb1134 · Cited by 3
Induced pluripotent stem cell modeling of genetic small vessel disease
Newman, K., Argyriou, A., & Wang, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-822227-0.00007-7 · Cited by 3
Insight into Notch Signaling Steps That Involve pecanex from Dominant-Modifier Screens in Drosophila
Yamakawa, T., Atsumi, Y., Kubo, S., Yamagishi, A., Morita, I., & Matsuno, K. (2018) · Genetics · doi:10.1534/genetics.118.300935 · Cited by 3
A novel Notch 3 mutation (pathogenic variant c.1565G>C) in CADASIL
Rodriguez, C. A., Fustes, O. J. H., & Arteaga, C. B. T. (2021) · Neurología · doi:10.1016/j.nrl.2021.03.013 · Cited by 3
Rackimuthu, S., Ahmed, S., Ishwara, P. R. P., Richie, A. J., & Colaco, K. V. C. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00502-9 · Cited by 3
“Heterozygous missense mutations in NOTCH3 gene are linked to CADASIL [3, 4].”
BackgroundCheng, Y., Liao, Y., Chen, C., Chung, C., Fann, C. S. J., Chang, C.-S., Lee, Y., & Tang, S. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.032689 · Cited by 3
Demeusy, V., Roche, F., Vincent, F., Taha, M., Zhang, R., Jouvent, É., Chabriat, H., & Lebenberg, J. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108936 · Cited by 3
Self-citationEpidemiology, risk factors, pathophysiology and causes of transient ischemic attacks and stroke
Pendlebury, S. T., Giles, M. F., & Rothwell, P. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575815.002 · Cited by 3
CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY (CADASIL)
Chabriat, H., & Bousser, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.019 · Cited by 3
Self-citationSQSTM1 gene as a potential genetic modifier of CADASIL phenotype
Almeida, M. R., Silva, A. R., Elias, I., Fernandes, C., Machado, R., Galego, O., & Cordeiro, G. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10308-5 · Cited by 3
Detection of Vascular Notch3 Deposits in Unfixed Frozen Skin Biopsy Sample in CADASIL
Ueda, A., Nakajima, M., Misumi, Y., Nakahara, K., Shinriki, S., Tasaki, M., Matsui, H., & Ueda, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.881528 · Cited by 3
Diagnosing Vascular Dementia by Skin Biopsy - Uniqueness of CADASIL
Tikka, S., Mykkänen, K., Junna, M., Bergholm, R., Pöyhönen, M., Baumann, M., Viitanen, M. H., & Kalimo, H. (2011) · InTech eBooks · doi:10.5772/24709 · Cited by 3
“Thus, most diagnostic laboratories screen only the exons that according to the previous reports harbour majority of the mutations (Dotti et al., 2005, Escary et al., 2000, Joutel et al., 1997, Kalimo et al., 2002, Opherk et al., 2004).”
BackgroundReaching a Diagnosis of a Dementia Subtype
Chui, H. C., Lee, A., Cummings, J. L., Tierney, M. C., Payami, H., Guzmán, J. D., Maríamillán, J., Muñoz, D. G., Bermejo, F., Bosscher, L., et al. (2003) · Wiley eBooks · doi:10.1002/9780470752340.ch16 · Cited by 3
SÍNDROME CADASIL: EPIDEMIOLOGIA, CLÍNICA E
Correia, N. M. F. (2011) · Cited by 3
Liu, G. T., Volpe, N. J., & Galetta, S. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-2311-1.00004-4 · Cited by 3
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Chabriat, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-56210-0_6 · Cited by 3
Self-citationCalcium‐Binding EGF ‐Like Domains
Boswell, E. J., Kurniawan, N. D., & Downing, A. K. (2004) · Wiley eBooks · doi:10.1002/0470028637.met048 · Cited by 3
Chabriat, H., Biard, L., Guey, S., Alili, N., Machado, C., Jabouley, A., Reyes, S., Lebenberg, J., Guillonnet, A., Dubus, E., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103853 · Cited by 2
“3,4 All pathogenic variants alter the number of cysteine residues within epidermal growth factor–like repeats in the extracellular domain, resulting in the accumulation of misfolded NOTCH3 protein in the vessel wall.”
Self-citationGenetische Forschung in der Psychiatrie: Fortschritt und Ethische Verantwortung
Deckert, J., & Arolt, V. (2001) · Springer eBooks · doi:10.1007/978-3-642-56818-3_24 · Cited by 2
A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL
Li, J., Luo, T., Wang, X., Wang, M., Zheng, T., Dang, X., Deng, A., Zhang, Y., Ding, S., Jing, P., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.943117 · Cited by 2
“Arg133Cys) in a Caucasian patient in 1997 (Joutel et al., 1997).”
BackgroundLee, S. J., Zhang, X., Xu, G., Borjigin, J., & Wang, M. M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102772 · Cited by 2
“The overwhelming majority of CADASIL mutations affect the number of cysteines in the NOTCH3 gene product (4, 5), a characteristic that is capable”
Unusual Clinical Presentations in Subjects Carrying Novel NOTCH3 Gene Mutations
Spinicci, G., Conti, M., Cherchi, M. V., Mancosu, C., Murru, R., & Carboni, N. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.02.002 · Cited by 2
Ungaro, C., Servillo, P., Mazzei, R., Consoli, D., Conforti, F. L., Sprovieri, T., Lanza, P. L., & Quattrone, A. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0040-z · Cited by 2
“uk/ac/index.php). Arg1231Cys is a missense mutation concerning the EGF-like repeat 31 of the NOTCH3 gene [ 1 ].”
BackgroundAPOEandAGTin the Finnish p.Arg133Cys CADASIL population
Siitonen, M., Mykkänen, K., Pescini, F., Rovio, S., Kääriäinen, H. A., Baumann, M., Pöyhönen, M., & Viitanen, M. H. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12400 · Cited by 2
“This homogeneity makes our population exceptional among other large CADASIL populations (3, 4).”
BackgroundMeschia, J. F. (2008) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000275628.24690.79 · Cited by 2
“Mutations lead to loss or gain of a cysteine, thereby creating an odd number of cysteines within a given EGF domain (Joutel et al, 1997).”
BackgroundMicrobleeds in relation to specific populations, diseases and neurological symptoms
Werring, D. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974892.012 · Cited by 2
Increased PKR level in human CADASIL brains
Cognat, E., Tible, M., Methnani, I., Chabriat, H., Adle‐Biassette, H., Hugon, J., & Paquet, C. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2425-y · Cited by 2
Self-citationBenisty, S., & Chabriat, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-49586-2_7 · Cited by 2
Self-citationHow understudied populations leverage our understanding of Alzheimer’s disease genetics
Dehghani, N., Brás, J., & Guerreiro, R. J. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.044901 · Cited by 2
Genetics and Genomics of Stroke
Tan, R. Y. Y., & Markus, H. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-66114-8_24 · Cited by 2
Tamhankar, M. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-34044-1.00004-3 · Cited by 2
Vascular cognitive impairment associated with NOTCH3 Exon 33 mutation: A case report
Sun, Y., Wei, Y., & Xing, Y. (2019) · Medicine · doi:10.1097/md.0000000000016920 · Cited by 2
“Joutel et al reported that 70% to 80% of French NOTCH3 gene mutations occur in exon 3 or 4, and exon 4 mutations are the most common.([27]) Markus et al reported that in the UK family of CADASIL-related NOTCH3 gene mutations, 73% are located in exon 4 and 8% in exon 3.”
Qureshi, A. I., Khan, M. T., Naveed, O., & Saleem, M. A. (2017) · Journal of vascular and interventional neurology · Cited by 2
Prayson, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-044306901-7.50024-9 · Cited by 2
Green, M. W., & Colman, R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800901-7.00006-9 · Cited by 2
Felczak, P., Cudna, A., Błażejewska‐Hyżorek, B., Buczek, J., Kurkowska‐Jastrzębska, I., Stępień, T., Acewicz, A., & Wierzba‐Bobrowicz, T. (2021) · Polish Journal of Pathology · doi:10.5114/pjp.2021.109517 · Cited by 2
Graham, J., & Potyk, D. K. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52277_14.x · Cited by 2
"Sindrome Cadasil: Epidemiologia, Clínica e Genética"
Correia, N. M. F. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/s8xb-a092 · Cited by 2
Rutten, J. W., van den Akker, E. B., & Oberstein, S. A. J. L. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0681-4 · Cited by 2
“Arg1231Cys variant is located in EGFr domain 31 of the NOTCH3 protein and has been reported as causative in multiple CADASIL pedigrees [5, 6].”
BackgroundGerritsen, M. E. (2008) · Wiley eBooks · doi:10.1002/cphy.cp020408 · Cited by 2
Ringelstein, E. B. (2001) · Steinkopff eBooks · doi:10.1007/978-3-642-57629-4_18 · Cited by 4
Nan, H., Chu, M. K., Yue, A., He, Q., Li, J., Liu, Y., Chi, L., Liu, X., Peng, G., & Wu, L. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01836-1 · Cited by 1
“Currently, over 200 pathogenic NOTCH3 variants, predominantly missense variants in exons 2–24, have been reported to cause CADASIL [9, 10].”
Cerebral microbleeds inCADASIL
Viswanathan, A., Chabriat, H., & Dichgans, M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974892.018 · Cited by 1
Self-citationWorsening Neurologic Deficits in a Pilot
Jewell, N. R., Tunell, G. L., Bouffard, J., & Opatowsky, M. J. (2006) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2006.11928207 · Cited by 1
“This may relate to deletional mutations or mutations within the noncoding sequence of the gene that can be missed by PCR (2, 11).”
BackgroundInfluentialClinicogenetic and Pathologic Characteristics of CADASIL
Roberts, K. A., O’Rourke, K., & Ross, O. A. (2012) · Springer eBooks · doi:10.1007/978-0-85729-209-4_6 · Cited by 1
“Ninety percent of mutations are found within exons 2–6 [ 75, 76 ] .”
BackgroundChapter 11 Vascular Cognitive Impairment
Erkinjuntti, T., & Kalaria, R. N. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70062-0 · Cited by 1
Chapter 18 Clinical genetic issues in stroke
Brenner, D. A., Alberts, M. J., & Amarenco, P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)01918-0 · Cited by 1
Maman, L., Stieltjes, N., Galéazzi, J.-M., Kalafat, M., & Alantar, A. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.09.005 · Cited by 1
Introduction to Stroke Genomics
Read, S., & Barone, F. C. (2004) · Humana Press eBooks · doi:10.1385/1-59259-836-6:003 · Cited by 1
Pathogenic aspects of hereditary small vessel disease of the brain
Joutel, A. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.008 · Cited by 1
Self-citationDiener, H., & Kurth, T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10036-3 · Cited by 1
Chabriat, H. (2017) · Primer on Cerebrovascular Diseases · doi:10.1016/b978-0-12-803058-5.00122-3 · Cited by 1
Self-citationLA DEMENZA VASCOLARE SOTTOCORTICALE: LUCI ED OMBRE
Zelante, G., Catalano, A., Ricceri, R., Rampello, L., & Rampello, L. (2012) · Cited by 1
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Ungaro, C., & Sprovieri, T. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87248 · Cited by 1
Not Described Variant of Notch3 Gen for Cadasil Disease
Mellinger, S., Romero, D., Visich, A., Chanampa, S., Ivetich, G., Burgos, M., & Orzuza, G. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104803 · Cited by 1
A novel Notch 3 mutation (pathogenic variant c.1565G>C) in CADASIL
Rodriguez, C. A., Fustes, O. J. H., & Arteaga, C. B. T. (2022) · Neurología (English Edition) · doi:10.1016/j.nrleng.2021.03.009 · Cited by 1
Ni, F.-L., Dai, J.-F., Zhang, W., Hou, Q., & Zhang, J. (2022) · Neurology Asia · doi:10.54029/2022tyx · Cited by 1
Patient with CADASIL – a diagnostic challenge
Węgrzynek‐Gallina, J., Tomaszewska, A., & Wawrzkiewicz‐Witkowska, A. (2023) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/162215 · Cited by 1
Detecting a Novel NOTCH3 Variant in Patients with Suspected CADASIL: A Single Center Study
Şanlı, Z. S., & Anlaş, Ö. (2023) · Molecular Syndromology · doi:10.1159/000534243 · Cited by 1
“…to its highly conserved structure, NOTCH3 extracellular domain mutations may have various functional consequences on the Notch3 receptor, including abnormal dimerization or folding, deterioration of interaction with its ligands, or aberrant interaction with another protein [Joutel et al., 1997].”
BackgroundCADASIL – obraz kliniczny, diagnostyka i leczenie
Dziewulska, D. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Emerging Genomic Biomarkers In Migraine
Menon, S., & Griffiths, L. R. (2012) · Future Neurology · doi:10.2217/fnl.12.80 · Cited by 1
A room from Jean-Martin Charcot’s house at the Metropolitan Museum of Art
Pourfar, M. (2005) · Neurology · doi:10.1212/01.wnl.0000182294.09191.26 · Cited by 1
Stroke: A Potential Risk Factor of Neurodegenerative Disorders
Camargo, C. H. F., Canever, M., Scavasine, V. C., & Lange, M. C. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch007 · Cited by 1
Diener, H., & Kurth, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00043-8 · Cited by 1
Xiao, S., Ke, M., Cai, K., Xu, A., & Chen, M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1400537 · Cited by 1
“Additionally, the mean transit time, time to peak, and T max were longer than those on the contralateral side; the volume of the core infarct area was 48.6 mL, and the mismatch volume was 41.8 pericytes (18).”
BackgroundInfluentialGerritsen, M. E. (1984) · Comprehensive physiology · doi:10.1002/j.2040-4603.1984.tb01017.x · Cited by 1
Manso-Calderón, R. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.123009 · Cited by 1
The Long Reach of Evolution and Development: Effects on the Alzheimer Brain
Kosik, K. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05563.x · Cited by 1
NOTCH3-related CADASIL and Non-NOTCH3-related CADASIL-like syndrome
Mizuno, T., Hosomi, A., Nagakane, Y., Oshima, F., Tomimoto, H., & Nakagawa, M. (2008) · Nosotchu · doi:10.3995/jstroke.30.897 · Cited by 1
Correlation between mutations and age in cystic fibrosis in a French Canadian population
Rivard, S. R., ALLARD, C., LEBLANC, J.-P., MILOT, M., AUBIN, G., SIMARD, F., Férec, C., & Braekeleer, M. D. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.225 · Cited by 1
Vascular smooth muscle cell is the primary target of events leading from notch3 mutations to cadasil
Joutel, A., François, A., Gaulis, S., Chapon, F., Godfrain, C., & Tournier‐Lasserve, E. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82709-8 · Cited by 1
“the 34 EGF-like repeats, which normally contains an invariable number of 6 cysteine residues (Fig. 2; Joutel et al. 1997; 2000a; Dichgans et al. 1998).”
BackgroundSelf-citationMendelian and complex causes of migraine: Bridging the gap
Joutel, A., & Debette, S. (2010) · Cephalalgia · doi:10.1177/0333102410384637 · Cited by 1
“loss or gain of a cysteine residue [12]), explain the increased risk of migraine in carriers of the rs1043994 variant? From a clinical point of view, it might be interesting to look for an interaction between rs1043994 and CADASIL mutations, by testing whether rs1043994 has a modifying effect on the migraine phenotype…”
BackgroundSelf-citationWORK GROUP ON ALZHEIMER'S DISEASE AND OTHER DEMENTIAS
Rabins, P. V., Rovner, B. W., Rummans, T. A., Schneider, L. S., Tariot, P. N., & Blass, D. M. (2010) · Cited by 1
Kalaria, R. N., Cookson, N., Mizuno, T., Oakley, A. E., Singleton, A., Morris, C. M., Coulthard, A., Blank, S. C., Bushby, K., Nicoll, J. A. R., et al. (2001) · Springer eBooks · doi:10.1007/978-4-431-67899-1_53 · Cited by 1
de Paiva, A. R. B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-16102019-142301 · Cited by 1
NOTCH ing toward better understanding of CADASIL
Hedera, P. (2020) · Neurology · doi:10.1212/wnl.0000000000010507 · Cited by 1
“The vast majority of pathogenic mutations are located within exons 2–23 of the NOTCH3 gene and result in an odd number of cysteine residues either by a loss or gain of a cysteine amino acid.(5) NOTCH3 protein contains 34 epidermal growth factor (EGF)–like repeats and each EGF-like repeat contains 6 cysteines that form…”
BackgroundDunn, P. J. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.229972 · Cited by 1
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
Chabriat, H., Joutel, A., Tournier‐Lasserve, E., & Bousser, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00041-7 · Cited by 1
Self-citation
Metadata
- Authors
- Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., Bach, J.-F., & Tournier-Lasserve, E.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Hôpital Lariboisière (FR)
- bioMérieux (France) (FR)
- Genethon (France) (FR)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 350
- Issue
- 9090
- Pages
- 1511-1515
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153287135
- Cited by
- 682
- References
- 26
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 22 · 2023: 21 · 2022: 27 · 2021: 16 · 2020: 30 · 2019: 20 · 2018: 28 · 2017: 16 · 2016: 12 · 2015: 18 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CADASIL, Notch3, NOTCH3 mutations, EGF-like repeats, mutation clustering, diagnostic testing, cerebrovascular disease, leukoencephalopathy
- MeSH terms
- Receptor, Notch3, Cerebral Arterial Diseases, Cerebral Infarction, DNA Mutational Analysis, Epidermal Growth Factor, Genetic Testing, Genotype, Humans, Leukoencephalopathy, Progressive Multifocal, Mutation, Proto-Oncogene Proteins, Receptors, Cell Surface, Case-Control Studies, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.